Borrowings (Tables)

9 Months Ended

Sep. 30, 2023

Borrowings [Abstract]

Summary Of Borrowings

	As of September 30, 2023
(Dollars in thousands)	Maturity Date	Contractual ‎Facility		Balance, ‎Gross		Balance, ‎Net(1)		Stated ‎Interest Rate	Effective ‎Interest ‎Rate
Denominated in USD
Trust Preferred Securities (US)	April 30, 2027	$	27,913	$	27,913	$	27,117	9.63%	9.63%
Bank of America Credit Facility (US)	September 4, 2024		22,375		22,375		22,260	11.00%	11.00%
Cinemas 1, 2, 3 Term Loan (US)	October 1, 2024		21,061		21,061		20,805	8.31%	8.31%
Minetta & Orpheum Theatres Loan (US)(2)	November 1, 2023		8,000		8,000		7,998	8.22%	6.00%
U.S. Corporate Office Term Loan (US)	January 1, 2027		8,471		8,471		8,422	4.64% / 4.44%	4.61%
Union Square Financing (US)	May 6, 2024		55,000		46,840		46,447	12.52%	12.52%
Purchase Money Promissory Note (US)	September 18, 2024		776		776		776	5.00%	5.00%
Denominated in foreign currency ("FC") (3)
NAB Corporate Term Loan (AU)	July 31, 2025		64,831		64,831		64,708	5.85%	5.85%
Westpac Bank Corporate (NZ)	January 1, 2024		8,322		8,322		8,322	8.20%	8.20%
		$	216,749	$	208,589	$	206,855

(1)Net of deferred financing costs amounting to $1.7 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 6.00%.

(3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of September 30, 2023.

	As of December 31, 2022
(Dollars in thousands)	Maturity Date	Contractual ‎Facility		Balance, ‎Gross		Balance, ‎Net(1)		Stated ‎Interest ‎Rate	Effective ‎Interest ‎Rate
Denominated in USD
Trust Preferred Securities (US)	April 30, 2027	$	27,913	$	27,913	$	26,950	8.41%	8.41%
Bank of America Credit Facility (US)(5)	March 1, 2024		26,750		26,750		26,663	10.00%	10.00%
Cinemas 1, 2, 3 Term Loan (US)(5)	April 1, 2023		22,455		22,455		22,208	6.63%	6.63%
Minetta & Orpheum Theatres Loan (US)(2)	November 1, 2023		8,000		8,000		7,974	7.12%	5.15%
U.S. Corporate Office Term Loan (US)	January 1, 2027		8,674		8,674		8,613	4.64% / 4.44%	4.64%
Union Square Financing (US)(3)	May 6, 2024		55,000		43,000		42,484	11.25%	7.40%
Purchase Money Promissory Note (US)	September 18, 2024		1,333		1,333		1,333	5.00%	5.00%
Denominated in foreign currency ("FC")(4)
NAB Corporate Term Loan (AU)	June 30, 2024		68,731		68,731		68,662	4.82%	4.82%
Westpac Bank Corporate (NZ)	January 1, 2024		8,777		8,777		8,777	6.95%	6.95%
Total		$	227,633	$	215,633	$	213,664

(1)Net of deferred financing costs amounting to $2.0 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provided for an effective fixed rate of 5.15%.

(3)The interest rate derivative associated with the Union Square loan provided for an effective fixed rate of 7.40%.

(4)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2022.

(5)This financing facilities were extended after December 31, 2022.

Schedule Of Long-term Debt Instruments, Net Of The Deferred Financing Costs

	September 30,		December 31,
Balance Sheet Caption (Dollars in thousands)	2023		2022
Debt - current portion	$	40,402	$	37,279
Debt - long-term portion		138,560		148,688
Subordinated debt - current portion		776		747
Subordinated debt - long-term portion		27,117		26,950
Total borrowings	$	206,855	$	213,664